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患有 AD 病的进行诊断。随机森林算法能够从 MRI 的高维数据中学习到其低维特征和低























Alzheimer’s disease (AD) is one of the most common diseases in the world. It is a progressive 
neurodegenerative that leads to memory loss and cognition impairment. There is no known 
curative treatment for AD. Early detection of AD is, therefore, an important area of research both 
in medical and computing fields. It has attracted researchers to find new methods concerning its 
development and early detection. 
In our research, we focused on early AD detection by using random forest methods. We 
applied random forest to fit out a scenario in AD diagnosis based on MRI data. The algorithm 
was able to learn features and characteristics from high dimension structural MRI data. The 
method detected the disease between AD classes and Normal Control (NC) subjects. It was also 
deployed in the detection of the very disease from NC to Mild Cognitive Impairment (MCI). 
We used datasets obtained from the ADNI to substantiate our research results. Based on the 
different features, we extended random forest algorithm on Magnetic Resonance Imaging (MRI) 
data to detect the disease through the use of several methods of dimensional variable reduction 
and data types. 
Our main contribution in this thesis centers on extending random forest to fit our AD 
research scenario. We came up with the New Random Forest (NRF) algorithm which learns and 
classifies AD data better than other algorithms. It is able to handle thousands of input variables 
without deletion as well as classify large amounts of data with high accuracy and give an 
estimation of what important variables are in the diagnosis classification.  
Our method overall performed better with 93% classification accuracy for sensitivity and 
81% for specificity on our datasets. This was a marginal performance compared to what other 
algorithms had accomplished. We hope that this thesis can provide a great springboard for other 
research activities in this area. 
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Chapter 1 Introduction 
1.1Background 
Alzheimer’s Disease (AD) is named after physician Alois Alzheimer’s. It is a condition defined 
by progressive AD, structures [8] and neuropathological features present in the brain. The 
earliest symptom is mostly impression loss, followed by effective and cognitive impairment. The 
participants become less able to perform even basic tasks [5]. It’s the most common cause of 
dementia in elderly people, with a worldwide prevalence that is expected to develop from 26.6 
million reported in 2006 to over 100 million in 2050 [3, 9].  
However, the representative handling of problems can manage the behavioral symptoms. 
Medical trials are focused on the development of new treatments which aim to reduce the risk of 
developing the disease [5].  Any disease cause treatment will therefore likely be the biggest 
benefit to asymptomatic people at high risk of increasing AD, called pre-symptomatic patients 
[10]. It is interesting because it may be a transitional phase related to the cognitive declines in 
normal aging and established AD [11]. Memory is impaired in MCI, although the general 
cognitive function is preserved, and patients are at rising risk of AD [5, 12]. The rate from MCI 
and AD was around 12% [5, 13]. 
The detection of AD is made with criteria such as the NINCDS-ADRDA [7] 
Alzheimer’s criteria [13]. They provide guidelines for patients classified as clear, possible, or 
possible AD [14]. AD needs neuropathological discovery confirmed by direct analysis of brain 
substance. Since their proposal in 1984, researchers have shown these criteria to have a 
diagnostic accuracy of up to 90%.  
Although, various major stand need to be inscribed [15, 16]. These include symptomatic 
before diagnosis, different detection, evaluation and prediction of progression [17]. Research 
has shown biochemical and neuroimaging biomarkers to have a diagnosis and prognostic value 
of AD. The revisions published to the consensus criteria aim to incorporate these advances [14]. 
The suspension of one year in this disease still progresses the reduction of the number of AD 















impersonal action. If a successful disease- modifying therapy AD is the early recognition to be 
developed in which will be initial distinguished. 
In Figure 1, it illustrates in 2015 the United States was the first country among the 
developed countries which had the highest number of people affected by AD. This number 
includes estimates of approximately 200,000 individual below age 65 that have younger-onset 
Alzheimer’s Disease [18, 19].  
 
 
Figure 1 Population has AD in the United States by 2015 
More women have AD and other dementia than men [20, 21]. Almost two –thirds of 
Americans with AD are women [21] of the 5.1 million people age 65 and above in the U.S, 3.2 
million are women and 1.9 million are men [21]. Based on estimation from ADAMS, people age 
71 and older. Many more women have AD and other types of dementia compared with men [20, 
21]. In developing countries, the fastest growing elderly people are in China, India and their 
south Asian and western Pacific neighbors.  
In 2010, Europe reported 10 million AD cases and based on the United Nation’s 
demographic forecast it will increase to 14 million by 2030. It is projected that by 2050, people 
aged 60 and over will account for 22% of the world’s population with four-fifths living in Asia, 
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